Dapagliflozin suppresses glucagon signaling in rodent models of diabetes

May-Yun Wang(The University of Texas Southwestern Medical Center), Michael G. Roth(The University of Texas Southwestern Medical Center)
Proceedings of the National Academy of Sciences
June 5, 2017
10.1073/pnas.1705845114
Cited by 33

Related Papers

SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers
|Nature Communications|2017|115
Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway
|Proceedings of the National Academy of Sciences|2015|112
Inhibition of Iron Uptake Is Responsible for Differential Sensitivity to V-ATPase Inhibitors in Several Cancer Cell Lines
|PLoS ONE|2010|26